ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting
Despite achieving recommended low-density lipoprotein cholesterol (LDL-C) targets, many patients remain at high risk of cardiovascular events due to elevated triglyceride-rich lipoproteins and remnants. Angiopoietin-like protein 3 (ANGPTL3) has emerged as a promising therapeutic target for addressin...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-01-01
|
| Series: | Frontiers in Endocrinology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1706091/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|